Giossi, Riccardo http://orcid.org/0000-0002-7352-9445
Carrara, Federica
Mazzari, Martina
Lo Re, Francesco
Senatore, Michele
Schicchi, Azzurra
Corrù, Federica
Fittipaldo, Veronica Andrea
Pani, Arianna
Tramacere, Irene
Elia, Antonio Emanuele
Scaglione, Francesco
Funding for this research was provided by:
Università degli Studi di Milano
Article History
Accepted: 5 February 2021
First Online: 5 March 2021
Declarations
:
: Open access funding provided by Università degli Studi di Milano within the CRUI-CARE Agreement.
: Riccardo Giossi reports non-financial support for congress participation from Mylan, outside the submitted work. Prof. Francesco Scaglione reports grants from Pfizer, lecture fees from Novartis and MSD, and has served on advisory board for GSK, outside the submitted work. Other authors declare no financial or other conflicts of interest.
: Not applicable.
: Not applicable.
: Not applicable.
: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
: Not applicable.
: R.G. contributed to study conception and design, data acquisition, analysis and interpretation, and paper drafting. F.C., M.M., F.L.R., M.S., A.S., F.C. contributed to data acquisition and analysis. V.A.F. contributed to study design and data acquisition. A.P. gave critical revision for intellectual content. I.T. contributed to data analysis and interpretation, paper drafting, and gave critical revision. A.E.E. contributed to data interpretation, paper drafting, and gave critical revision for intellectual content. F.S. gave critical revision for intellectual content.
: None.